Search Results - Marlies de Graaf

Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis by Roselie Achten, Lisa van der Rijst, Marjanne Piena, Hedda Lamers, Fleur de Beer, Marjolein de Bruin-Weller, Marlies de Graaf

Connect to this object online.

Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps by Lisa P. van der Rijst, Annet van Royen-Kerkhof, Suzanne G. M. A. Pasmans, Renske Schappin, Marjolein S. de Bruin-Weller, Marlies de Graaf

Connect to this object online.

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry by Celeste M. Boesjes, Liana F. van der Gang, Nicolaas P.A. Zuithoff, Daphne S. Bakker, Lotte S. Spekhorst, Inge Haeck, Marijke Kamsteeg, Marlies de Graaf, Marjolein S. de Bruin-Weller

Connect to this object online.

Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema by Floor M. Garritsen, Jorien van der Schaft, Marlies de Graaf, Dirk Jan Hijnen, Carla A.F. Bruijnzeel-Koomen, Marcel P.H. van den Broek, Marjolein S. De Bruin-Weller

Connect to this object online.

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry by Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, Marijke Kamsteeg, Inge Haeck, Anneke M.T. van Lynden-van Nes, Klaziena Politiek, Liana F. van der Gang, Marlies de Graaf, Marjolein S. de Bruin-Weller, Marie L.A. Schuttelaar

Connect to this object online.

Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis by Roselie E. Achten, Chantal van Luijk, Lisa van der Rijst, Daphne Bakker, Lotte Spekhorst, Nicolaas Zuithoff, Marie Schuttelaar, Geertruida Romeijn, Angelique Voorberg, Marijke Kamsteeg, Inge Haeck, Marlies de Graaf, Judith Thijs, Joke de Boer, Marjolein de Bruin-Weller

Connect to this object online.

Juvenile interleukin-36 receptor antagonist deficiency (DITRA) with c.80T>C (p.Leu27Pro) mutation successfully treated with etanercept and acitretin by Edwin Cuperus, MD, Rosanne Koevoets, MD, PhD, Jasper J. van der Smagt, MD, Johan Toonstra, MD, PhD, Marlies de Graaf, MD, PhD, Joost Frenkel, MD, PhD, Suzanne G.M.A. Pasmans, MD, PhD

Connect to this object online.

Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs by Floor M. Garritsen, Jorien van der Schaft, Juul M. Reek, Klaziena Politiek, Harmieke van den Os-Medendorp, Marijke van Dijk, Dirk J. Hijnen, Marlies de Graaf, Carla A. Bruijnzeel-Koomen, Elke M. de Jong, Marie-Louise A. Schuttelaar, Marjolein S. Bruin-Weller

Connect to this object online.

Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry by Celeste M. Boesjes, Esmé Kamphuis, Nicolaas P.A. Zuithoff, Daphne S. Bakker, Laura Loman, Lotte S. Spekhorst, Inge Haeck, Marijke Kamsteeg, Anneke M.T. van Lynden-van Nes, Floor M. Garritsen, Klaziena Politiek, Marja Oldhoff, Marlies de Graaf, Marie L.A. Schuttelaar, Marjolein S. de Bruin-Weller

Connect to this object online.

Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers by Mireille M. Hermans, Suzanne G.M.A. Pasmans, Marlies de Graaf, Aviël Ragamin, Elodie J. Mendels, Johannes M.P.J. Breur, Hester R. Langeveld, Martine F. Raphael, Peter C.J. de Laat, Saskia N. de Wildt, André B. Rietman, Corstiaan C. Breugem, Renske Schappin

Connect to this object online.

Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma by Mireille M. Hermans, Corstiaan C. Breugem, Renske Schappin, Emma Jonge Poerink, Elodie J. Mendels, Aviël Ragamin, Johannes M.P.J. Breur, Hester R. Langeveld, Martine F. Raphael, Peter C.J. de Laat, Saskia N. de Wildt, André B. Rietman, Suzanne G.M.A. Pasmans, Marlies de Graaf

Connect to this object online.

Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health by Mireille M. Hermans, MSc, Suzanne G.M.A. Pasmans, MD, PhD, Peter C.J. de Laat, MD, PhD, Martijn G. Slieker, MD, PhD, Elodie J. Mendels, MD, Marlies de Graaf, MD, PhD, Hester R. Langeveld, MD, PhD, Renske Schappin, PhD, André B. Rietman, PhD, Corstiaan C. Breugem, MD, PhD, Johannes M.P.J. Breur, MD, PhD, Saskia N. de Wildt, MD, PhD, Martine F. Raphael, MD, PhD

Connect to this object online.